These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38509625)

  • 1. Post-marketing surveillance of zinc acetate dihydrate for hypozincemia in Japan.
    Ezoe S; Ishihara T; Hosogai T; Kokubo T
    Pharmazie; 2024 Feb; 79(1):29-34. PubMed ID: 38509625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Decreased Serum Copper Concentrations by Zinc Administration in Preterm Infants with Hypozincemia Are Associated with a Lower Postmenstrual Age: A Single-center Retrospective Observational Study].
    Ito T; Uenoyama K; Kobayashi K; Kakumoto M; Mizumoto H; Katsura T; Onoue M
    Yakugaku Zasshi; 2022; 142(9):999-1004. PubMed ID: 36047227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Zinc Acetate Dihydrate (NobelzinR) Treatment on Anemia and Taste Disorders in Patients with Chronic Kidney Disease with Hypozincemia.
    Sato D; Gohda T; Kihara M; Kanaguchi Y; Kobayashi T; Mano S; Sasaki Y; Nohara N; Murakoshi M; Nakata J; Suzuki H; Ueda S; Horikoshi S; Suzuki Y
    Acta Med Okayama; 2018 Oct; 72(5):535-538. PubMed ID: 30369613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of zinc to preterm infants with hypozincemia does not reduce serum copper concentrations in most cases: a single-center retrospective observational study.
    Ito T; Uenoyama K; Kobayashi K; Kakumoto M; Mizumoto H; Katsura T; Onoue M
    J Pharm Health Care Sci; 2021 Dec; 7(1):46. PubMed ID: 34852847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective study on the therapeutic efficacy of zinc acetate hydrate administration to patients with hypozincemia-induced dysgeusia.
    Shintani T; Ohta K; Ando T; Hayashido Y; Yanamoto S; Kajiya M; Shiba H
    BMC Oral Health; 2023 Mar; 23(1):159. PubMed ID: 36934261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Zinc Acetate Treatment for Patients with Decompensated Liver Cirrhosis Complicated by Hypozincemia.
    Horiguchi S; Naganuma A; Tateyama Y; Suzuki Y; Hoshino T; Saito N; Hatanaka T; Takakusagi S; Kosone T; Takagi H; Uraoka T; Kakizaki S
    Biol Trace Elem Res; 2022 Feb; 200(2):497-504. PubMed ID: 33913092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc acetate treatment in Wilson's disease.
    Anderson LA; Hakojarvi SL; Boudreaux SK
    Ann Pharmacother; 1998 Jan; 32(1):78-87. PubMed ID: 9475826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism.
    Shimizu N; Fujiwara J; Ohnishi S; Sato M; Kodama H; Kohsaka T; Inui A; Fujisawa T; Tamai H; Ida S; Itoh S; Ito M; Horiike N; Harada M; Yoshino M; Aoki T
    Transl Res; 2010 Dec; 156(6):350-7. PubMed ID: 21078496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Durable Safety and Effectiveness of Lixisenatide in Japanese People with Type 2 Diabetes: The Post-Marketing Surveillance PRANDIAL Study.
    Terauchi Y; Usami M; Inoue T
    Adv Ther; 2022 Jun; 39(6):2873-2888. PubMed ID: 35449321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of canagliflozin in elderly patients with type 2 diabetes mellitus: a 1-year post-marketing surveillance in Japan.
    Goda M; Yamakura T; Sasaki K; Tajima T; Ueno M
    Curr Med Res Opin; 2018 Feb; 34(2):319-327. PubMed ID: 29025285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-World Safety and Effectiveness of Canagliflozin Treatment for Type 2 Diabetes Mellitus in Japan: SAPPHIRE, a Long-Term, Large-Scale Post-Marketing Surveillance.
    Inagaki N; Nangaku M; Sakata Y; Sasaki K; Mori-Anai K; Iwasaki T; Hamada K
    Adv Ther; 2022 Jan; 39(1):674-691. PubMed ID: 34853985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Safety and Efficacy of Teneligliptin in Elderly Patients with Type 2 Diabetes: Subgroup Analysis of a 3-Year Post-Marketing Surveillance in Japan.
    Kadowaki T; Haneda M; Ito H; Sasaki K; Yamada Y
    Adv Ther; 2020 May; 37(5):2477-2492. PubMed ID: 32323194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc Acetate Dihydrate Tablet-associated Gastric Lesions.
    Iwamuro M; Tanaka T; Kuraoka S; Hamada K; Abe M; Kono Y; Kanzaki H; Kawano S; Kawahara Y; Okada H
    Intern Med; 2022; 61(13):1931-1938. PubMed ID: 35781269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Significance of Zinc in Patients with Chronic Liver Disease.
    Nishikawa H; Asai A; Fukunishi S
    Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Zinc Acetate Hydrate Supplementation on Renal Anemia with Hypozincemia in Hemodialysis Patients.
    Sato E; Sato S; Degawa M; Ono T; Lu H; Matsumura D; Nomura M; Moriyama N; Amaha M; Nakamura T
    Toxins (Basel); 2022 Oct; 14(11):. PubMed ID: 36355996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and effectiveness of istradefylline as add-on therapy to levodopa in patients with Parkinson's disease: Final report of a post-marketing surveillance study in Japan.
    Takahashi M; Ito S; Tsuji Y; Horiguchi S
    J Neurol Sci; 2022 Dec; 443():120479. PubMed ID: 36395674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety and effectiveness of velaglucerase alfa in Gaucher disease: 6-year interim analysis of a post-marketing surveillance in Japan.
    Sagara R; Ishigaki M; Otsuka M; Murayama K; Ida H; Fernandez J
    Orphanet J Rare Dis; 2021 Dec; 16(1):502. PubMed ID: 34863216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of zinc acetate hydrate for hypozincemia in the elderly is influenced by the initial accumulated exposure dose after taking zinc acetate hydrate.
    So M; Tsuji Y; Suzuki T
    Pharmazie; 2023 Oct; 78(9):201-206. PubMed ID: 38037215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Japan's Practical Guidelines for Zinc Deficiency with a Particular Focus on Taste Disorders, Inflammatory Bowel Disease, and Liver Cirrhosis.
    Kodama H; Tanaka M; Naito Y; Katayama K; Moriyama M
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc acetate for the treatment of Wilson's disease.
    Brewer GJ
    Expert Opin Pharmacother; 2001 Sep; 2(9):1473-7. PubMed ID: 11585025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.